Direct comparison
Royalty vs. Equity Licensing Compensation
How universities choose royalty, equity, or hybrid compensation when licensing patents to startups, and why cash-poor licensees change the calculus.
Ask about Royalty vs. Equity Licensing Compensation
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Running Royalty, Equity Stake, Hybrid Structure compare side by side?
The table below compares Running Royalty, Equity Stake, Hybrid Structure across 8 procurement-relevant dimensions, from what it is through common companion terms.
Side-by-side comparison
| Dimension | Running Royalty | Equity Stake | Hybrid Structure |
|---|---|---|---|
| What it is | A recurring percentage of the licensee's net product sales, paid for as long as the license and patent remain in force | Shares, units, or warrants in the licensee company, taken in place of or alongside cash consideration | A reduced running royalty combined with a smaller equity stake, often with milestone payments layered in |
| Requires licensee revenue | Yes -- generates nothing until the licensee has sales | No -- generates nothing until an exit, but doesn't depend on sales existing yet | Partially -- the royalty component still depends on sales, but the license isn't solely dependent on them |
| Typical licensee profile | Established company with existing or near-term product revenue | Early-stage, cash-poor startup unable to pay meaningful upfront fees or royalties | Startup with some near-term revenue prospect but still limited cash |
| When value is realized | Incrementally, as sales occur | Only on a liquidity event -- acquisition, IPO, or share sale; worthless if the company never exits | Both -- incremental royalty income plus potential exit value |
| Administrative burden | Moderate -- sales reports, audit rights, minimum royalty tracking | Higher -- cap-table monitoring, dilution tracking, conflict-of-interest oversight, eventual share disposition | Highest -- combines royalty administration with equity monitoring |
| Institutional risk profile | Lower -- tied directly to actual sales, no dependence on an exit event | Higher -- concentrated bet on one company's eventual success, subject to dilution | Balanced -- some cash exposure to sales, some upside exposure to an exit |
| Conflict-of-interest exposure | Standard license-level COI management | Elevated, especially if a faculty inventor is also a founder or officer of the licensee | Elevated, same as equity component |
| Common companion terms | Upfront fee, minimum annual royalties, patent cost reimbursement | Anti-dilution protection (or its deliberate absence), board observer/information rights | Milestone payments, reduced upfront fee, staged diligence obligations |
Common questions
Common questions about Running Royalty vs Equity Stake vs Hybrid Structure
Why would a university take equity instead of a royalty?
+
Because an early-stage, cash-poor startup often cannot pay a meaningful upfront fee or running royalty at all. Equity lets the institution capture value from the license in a form the startup can actually afford to give -- ownership -- rather than cash it doesn't have. The trade-off is that equity is only worth something if the company eventually has a liquidity event.
Is equity riskier for a university than a royalty?
+
Generally yes, in the sense that equity depends entirely on the licensee eventually being acquired, going public, or creating some other exit; a company that never exits leaves the equity stake worth nothing. A running royalty, by contrast, generates at least some cash the moment the licensee has any sales, however modest.
What is a hybrid royalty-equity licensing structure?
+
A license that combines a reduced running royalty with a smaller equity stake, and often milestone payments, rather than relying on one mechanism alone. It lets an institution's compensation track a startup's actual ability to pay cash at each stage of development while retaining some exposure to a future exit.
Does the university keep its equity stake forever?
+
Not necessarily -- institutional policy typically governs when and how the institution can sell shares it receives through a license, and whether the stake carries anti-dilution protection through subsequent financing rounds. This is usually addressed in the institution's own equity-holding and conflict-of-interest policies, not in the license agreement's core royalty terms.
